[{"address1": "400 Chesapeake Drive", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 241 7900", "website": "https://avinger.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.", "fullTimeEmployees": 68, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jeffrey M. Soinski", "age": 61, "title": "President, CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 616795, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nabeel P. Subainati", "age": 39, "title": "VP of Finance, Principal Financial Officer & Accounting Officer", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 347584, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Himanshu N. Patel", "age": 63, "title": "Chief Technology Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 430077, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Keith  Schaefer", "title": "Chief Operating Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip R. Preuss", "age": 45, "title": "Chief Marketing Officer & VP of Business Operations", "yearBorn": 1978, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Corey  Gibbs", "title": "Vice President of Sales", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jaafer  Golzar FACC, M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.14, "open": 4.25, "dayLow": 3.66, "dayHigh": 4.25, "regularMarketPreviousClose": 4.14, "regularMarketOpen": 4.25, "regularMarketDayLow": 3.66, "regularMarketDayHigh": 4.25, "beta": 1.324, "forwardPE": -0.42413795, "volume": 30312, "regularMarketVolume": 30312, "averageVolume": 55000, "averageVolume10days": 25090, "averageDailyVolume10Day": 25090, "marketCap": 5853927, "fiftyTwoWeekLow": 2.5, "fiftyTwoWeekHigh": 18.0, "priceToSalesTrailing12Months": 0.76501924, "fiftyDayAverage": 3.30014, "twoHundredDayAverage": 5.317425, "currency": "USD", "enterpriseValue": 15973941, "profitMargins": -2.39415, "floatShares": 1314551, "sharesOutstanding": 1586430, "sharesShort": 50302, "sharesShortPriorMonth": 23462, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0317, "heldPercentInsiders": 0.15853, "heldPercentInstitutions": 0.05881, "shortRatio": 0.54, "shortPercentOfFloat": 0.0339, "impliedSharesOutstanding": 1842240, "bookValue": -4.846, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -18320000, "trailingEps": -23.31, "forwardEps": -8.7, "lastSplitFactor": "1:15", "lastSplitDate": 1694563200, "enterpriseToRevenue": 2.088, "enterpriseToEbitda": -0.977, "52WeekChange": -0.6095238, "SandP52WeekChange": 0.21828604, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "AVGR", "underlyingSymbol": "AVGR", "shortName": "Avinger, Inc.", "longName": "Avinger, Inc.", "firstTradeDateEpochUtc": 1422628200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4434fc85-429f-3fc7-9434-7a74cb27103e", "messageBoardId": "finmb_98560456", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.69, "targetHighPrice": 5.0, "targetLowPrice": 5.0, "targetMeanPrice": 5.0, "targetMedianPrice": 5.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 5275000, "totalCashPerShare": 3.325, "ebitda": -16346000, "totalDebt": 15395000, "quickRatio": 0.326, "currentRatio": 0.63, "totalRevenue": 7652000, "revenuePerShare": 9.735, "returnOnAssets": -0.54771, "freeCashflow": -8354250, "operatingCashflow": -14432000, "revenueGrowth": -0.047, "grossMargins": 0.26176, "ebitdaMargins": -2.1361701, "operatingMargins": -2.4213, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-16"}]